Somatostatin receptor-targeted organometallic iridium(III) complexes as novel theranostic agents

Novohradsky, VojtechZamora, AnaGandioso, AlbertBrabec, ViktorRuiz, JoséMarchán Sancho, Vicente2017-07-102017-07-102017-04-251359-7345https://hdl.handle.net/2445/113562A novel somatostatin receptor-targeted anticancer agent based on the conjugation of a highly cytotoxic and luminiscent cyclometalated iridium(III) complex to tumor-targeting vectors based on octreotide peptide has been described, and its potential for targeted theranostic applications has been demonstrated.4 p.application/pdfengcc-by (c) Novohradsky, Vojtech et al., 2017http://creativecommons.org/licenses/by/3.0/esIridiCàncerSomatostatinaIridiumCancerSomatostatinSomatostatin receptor-targeted organometallic iridium(III) complexes as novel theranostic agentsinfo:eu-repo/semantics/article6710862017-07-10info:eu-repo/semantics/openAccess28466888